- Home
- ACN vs ABT Comparison
ACN vs ABT Comparison
Compare ACN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACN
- ABT
- Stock Information
- Founded
- ACN 1989
- ABT 1888
- Country
- ACN Ireland
- ABT United States
- Employees
- ACN N/A
- ABT N/A
- Industry
- ACN Business Services
- ABT Medical/Dental Instruments
- Sector
- ACN Consumer Discretionary
- ABT Health Care
- Exchange
- ACN Nasdaq
- ABT Nasdaq
- Market Cap
- ACN 189.5B
- ABT 177.5B
- IPO Year
- ACN N/A
- ABT N/A
- Fundamental
- Price
- ACN $339.80
- ABT $113.95
- Analyst Decision
- ACN Buy
- ABT Strong Buy
- Analyst Count
- ACN 20
- ABT 9
- Target Price
- ACN $348.25
- ABT $124.33
- AVG Volume (30 Days)
- ACN 1.8M
- ABT 4.3M
- Earning Date
- ACN 09-26-2024
- ABT 10-16-2024
- Dividend Yield
- ACN 1.52%
- ABT 1.93%
- EPS Growth
- ACN N/A
- ABT 8.34
- EPS
- ACN 11.10
- ABT 3.17
- Revenue
- ACN $64,475,845,000.00
- ABT $40,725,000,000.00
- Revenue This Year
- ACN $2.19
- ABT $5.10
- Revenue Next Year
- ACN $5.39
- ABT $7.34
- P/E Ratio
- ACN $30.63
- ABT $35.92
- Revenue Growth
- ACN 1.46
- ABT 1.24
- 52 Week Low
- ACN $278.69
- ABT $89.67
- 52 Week High
- ACN $387.51
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- ACN 62.56
- ABT 63.40
- Support Level
- ACN $338.98
- ABT $112.52
- Resistance Level
- ACN $345.54
- ABT $115.59
- Average True Range (ATR)
- ACN 4.97
- ABT 1.32
- MACD
- ACN 0.38
- ABT -0.03
- Stochastic Oscillator
- ACN 69.04
- ABT 68.82
About ACN Accenture plc (Ireland)
Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.